TAP deficiency syndrome

Clin Exp Immunol. 2000 Aug;121(2):173-8. doi: 10.1046/j.1365-2249.2000.01264.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 2
  • ATP Binding Cassette Transporter, Subfamily B, Member 3
  • ATP-Binding Cassette Transporters / chemistry
  • ATP-Binding Cassette Transporters / genetics
  • ATP-Binding Cassette Transporters / physiology*
  • Antigen Presentation
  • Biological Transport
  • Bronchiectasis / etiology
  • Child
  • Child, Preschool
  • Diagnosis, Differential
  • Dimerization
  • Genetic Predisposition to Disease
  • Granuloma / etiology
  • Granuloma / pathology
  • HLA Antigens / immunology
  • HLA Antigens / metabolism
  • Humans
  • Immunocompromised Host
  • Immunologic Deficiency Syndromes / diagnosis
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Infections / etiology
  • Interferons / therapeutic use
  • Major Histocompatibility Complex
  • Necrosis
  • Phenotype
  • Photochemotherapy
  • Sarcoidosis / diagnosis
  • Severe Combined Immunodeficiency / classification
  • Severe Combined Immunodeficiency / diagnosis
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / immunology
  • Severe Combined Immunodeficiency / therapy
  • Skin Diseases / etiology
  • Skin Diseases / pathology
  • Skin Ulcer / etiology
  • Skin Ulcer / therapy
  • Syndrome

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 2
  • ATP Binding Cassette Transporter, Subfamily B, Member 3
  • ATP-Binding Cassette Transporters
  • HLA Antigens
  • Immunosuppressive Agents
  • TAP1 protein, human
  • TAP2 protein, human
  • Interferons